Tadalafil
Back to searchMolecule Structure
Scientific Name
Tadalafil
Description of the Drug
Tadalafil is a phosphodiesterase 5 inhibitor used to treat erectile dysfunction, benign prostatic hyperplasia, and pulmonary arterial hypertension.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00820
http://www.drugbank.ca/drugs/DB00820
Brand Name(s)
Adcirca, Cialis, Tadliq
Company Owner(s)
Sunshine Lake Pharma Co Ltd, Cmp Development Llc, Cipla Ltd, Macleods Pharmaceuticals Ltd, Watson Laboratories Inc, Eli Lilly Co, Zydus Pharmaceuticals Usa Inc, Prinston Pharmaceutical Inc, Torrent Pharmaceuticals Ltd, Teva Pharmaceuticals Usa Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Phosphodiesterase 5A | SINGLE PROTEIN | INHIBITOR | CHEMBL1827 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL33333 | ||
PharmGKB | PA10333 | ||
Human Metabolome Database | HMDB0014958 | ||
DrugBank | DB00820 | ||
PubChem: Thomson Pharma | 14756405 | 14805118 | |
PubChem | 110635 | ||
LINCS | LSM-4109 | ||
Nikkaji | J1.662.659G | ||
PDBe | CIA | ||
BindingDB | 14777 | ||
EPA CompTox Dashboard | DTXSID9046786 | ||
DrugCentral | 2553 | ||
Brenda | 1339 | ||
ChemicalBook | CB2236841 | ||
Guide to Pharmacology | 7299 | ||
rxnorm | TADALAFIL | ADCIRCA | CIALIS |
PubChem: Drugs of the Future | 12015128 | ||
ChEBI | 71940 | ||
ZINC | ZINC000003993855 |